Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy


  • COPD — Pulmonology Mastery in COPD – Curriculum
  • Pulmonology Mastery in COPD is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in COPD. The curriculum includes ... more >>
    B. Make, MD
  • Multiple Myeloma — Hematology Mastery in Multiple Myeloma Video Roundtable – Video Presentation
  • Many scientific advances in the diagnosis and treatment of multiple myeloma have been made in recent years. Join Sagar Lonial, MD, and panelists Jonathan Kaufman, MD, and Ajay Nooka, MD, MPH, as they discuss the changes made by the International Myeloma Working Group to the definition of myeloma, the current ... more >>
    J. Kaufman, MD
    S. Lonial, MD
    A. Nooka, MD, MPH
  • Rheumatoid Arthritis — Profiles of Emerging Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis – @Point of Care Chapter
  • A number of emerging non-tumor necrosis factor biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), including interleukin 6 inhibitors and Janus kinase inhibitors, are in late-stage clinical testing for the treatment of rheumatoid arthritis. In this chapter, Dr. Eric Ruderman ... more >>
    E. Ruderman, MD
  • Rheumatoid Arthritis — Profiles of Approved Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis – @Point of Care Chapter
  • Tofacitinib, a Janus kinase (JAK) inhibitor, is currently the only approved targeted synthetic disease-modifying antirheumatic drug. Join Dr. Eric Ruderman to understand why JAK is an important target for rheumatoid arthritis therapy and for a review of tofacitinib efficacy and safety data. Throughout this ... more >>
    E. Ruderman, MD
  • Pulmonology Mastery in COPD
  • Pulmonology Mastery in COPD is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in COPD. The curriculum includes ... more >>
    B. Make, MD
  • Hematology Mastery in Multiple Myeloma
  • Hematology Mastery in Multiple Myeloma is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma. ... more >>
    N. Raje, MD
  • Rheumatology Mastery In Ankylosing Spondylitis
  • Rheumatology Mastery in Ankylosing Spondylitis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in ankylosing ... more >>
    J. Reveille, MD
  • Mastery of Medicine in Diabetes Management
  • Mastery of Medicine in Diabetes Management is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in diabetes ... more >>
    V. Fonseca, MD, FRCP
  • Rheumatology Mastery in Rheumatoid Arthritis
  • Rheumatology Mastery in Rheumatoid Arthritis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in rheumatoid ... more >>
    M. Husni, MD, MPH
  • Neurology Mastery in Multiple Sclerosis
  • Neurology Mastery in Multiple Sclerosis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple sclerosis. ... more >>
    J. Bowen, MD
  • Cardiology Mastery in Chronic Heart Failure
  • Cardiology Mastery in Chronic Heart Failure is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in chronic heart ... more >>
    C. Yancy, MD, MSc
  • Clinical Context: Diabetes
  • Clinical Context: Diabetes is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in diabetes. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that ... more >>
    V. Fonseca, MD, FRCP
  • Clinical Context: Gynecologic Cancers
  • Clinical Context: Gynecologic Cancers is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in gynecologic cancers. The curriculum includes case studies at the point of care and MedPage ... more >>
    B. Monk, MD, FACOG, FACS
  • Clinical Context: Migraine
  • Clinical Context: Migraine is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in migraine. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that ... more >>
    D. Friedman, MD, MPH
  • MedImage Cases: Multiple Sclerosis
  • MedImage Cases®: Multiple Sclerosis Edition provides a series of image-based case presentations, with audio commentary from renown experts, discussing the MRI as a tool to guide MS diagnosis, measurement of disease activity/progression, practical therapeutic interventions, and response to therapy. Clinicians ... more >>
    C. Azevedo, MD, MPH
    D. Pelletier, MD
  • Update - Making Sense of New and Emerging Treatment Options for COPD
  • Chronic obstructive pulmonary disease (COPD) is highly prevalent in the United States. About 13 million people have a diagnosis of COPD, yet the disease remains underdiagnosed, with an estimated 21 million individuals affected. Cigarette smoking is the primary cause and, while smoking rates have dropped, they ... more >>
    B. Make, MD
  • Asthma @Point of Care
  • Asthma @Point of Care™ platform provides a comprehensive knowledge base of current and emerging diagnostic and management strategies based on the most up-to-date scientific data and clinical trial results, guidance, and insights from top clinician specialists all delivered in ways to efficiently and ... more >>
    M. Wechsler, MD, MMSc
  • Diabetes @Point of Care
  • This reference tool is designed for busy clinicians who want the latest information on new tools to manage type 1 and 2 diabetes mellitus (T2DM). With an emphasis on self-monitoring of blood glucose and novel therapies, this platform explores how best to help patients achieve treatment goals. Features include ... more >>
    A. Garber, MD, PhD, FACE
    J. Green, MD
  • Skin Cancer @Point of Care
  • Skin Cancer @Point of Care platform provides a comprehensive examination of skin cancer clinical pathology and presentation, diagnosis, and the latest evidence-based data for optimizing surgical and treatment strategies for basal cell carcinoma and melanoma. In particular, current and emerging targeted ... more >>
    S. Feldman, MD, PhD
  • Stroke Prevention in Atrial Fibrillation and VTE @Point of Care
  • Stroke Prevention in Atrial Fibrillation and VTE @Point of Care is a clinical decision-making tool that provides a streamlined, comprehensive mobile reference for clinicians to obtain information on the diagnosis, treatment and management of Atrial Fibrillation and VTE. It is made up of a progressive series ... more >>
    S. Connolly, MD, FRCPC
  • Cystic Fibrosis @Point of Care
  • Major advancements, including newborn screening, new treatments targeting the underlying cause of disease, and quality improvement initiatives, have transformed the continuum of care and survival outcomes for individuals with cystic fibrosis. The Cystic Fibrosis @Point of Care Edition provides a comprehensive ... more >>
    S. McColley, MD
  • Chronic Lymphocytic Leukemia @Point of Care
  • Recently approved targeted therapies and emerging immunotherapies for chronic lymphocytic leukemia (CLL) are transforming patient outcomes and the standard of care. To achieve the best patient outcomes, clinicians need to implement individualized treatment plans based upon evaluation of patient ... more >>
    S. Gregory, MD
  • Idiopathic Pulmonary Fibrosis @Point of Care
  • This point-of-care eTextbook provides a thorough yet concise review of the epidemiology, etiology, and pathophysiology of idiopathic pulmonary fibrosis (IPF), its diagnosis and prognosis, and the latest evidence-based data on current and investigational treatment and management strategies with insights from ... more >>
    M. Padilla, MD
  • Multiple Myeloma @Point of Care
  • This point-of-care eHandbook delivers a thorough yet concise review of multiple myeloma (MM), its diagnosis and prognosis, and the latest evidence-based data on treatment strategies with insights from top clinical specialists on the novel and emerging therapies that are revolutionizing the management of MM. ... more >>
    S. Lonial, MD
  • Cardiovascular/Diabetes — Cardiovascular Challenges in Diabetes – Video Presentation
  • Although the association between the incidence of diabetes and that of heart failure is well known, the advent of new diabetic therapies now presents an opportunity to modify this interaction, thereby potentially improving outcomes. Join Drs. James Januzzi, Javed Butler, Christopher P. Cannon, Mikhail ... more >>
    J. Januzzi, MD
  • Primary Biliary Cirrhosis — New Perspectives in PBC – Webcast
  • Join David E. J. Jones, MD, PhD, and Christoper L. Bowlus, MD, to learn clinically relevant information about the diagnosis, profiling, and management of patients with primary biliary cholangitis (PBC). With the approval of obeticholic acid in May 2016, a new therapeutic option is available for your patients ... more >>
    D. Jones, MD, PhD
  • Primary Biliary Cirrhosis — New Perspectives in Cholestatic Disease and the Microbiome – Satellite Symposium

  • This live symposium has ended.

    Excerpts of the live presentations will be available soon in the form of an on-demand webcast. If you would like to be notified once it is available, please email us at pbcpscBoston@projectsinknowledge.com [Please put "PBC Webcast—Inform Me" in the subject line].

    ...
    more >>
    D. Jones, MD, PhD
  • Primary Biliary Cirrhosis — Profiling PBC Patients: A Sea-Change in Management – Satellite Symposium

  • LIVE BREAKFAST SYMPOSIUM--REGISTER NOW!

    Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic, immune-mediated cholangitis with bile duct loss and subsequent cholestasis. The subsequent liver damage results in inflammation and fibrosis with potential progression to ...
    more >>
    K. Kowdley, MD, AGAF, FAASLD, FACP, FACG, FASGE
  • Nonalcoholic Steatohepatitis — NASH: Diagnostic and Treatment Breakthroughs – Webcast
  • This 90-minute webcast, from the proceedings of the live symposium in San Francisco, features Program Chair, Dr. Zobair Younossi, and our distinguished faculty, Drs. Stephen Harrison and Rohit Loomba, who will provide expert insight into how novel therapeutic approaches for nonalcoholic steatohepatitis (NASH) ... more >>
    Z. Younossi, MD, MPH, FACP. FACG, AGAF
  • Primary Biliary Cirrhosis — PBC: Novel Pathways for Treatment of Cholestatic Liver Disease – Webcast
  • Chronic liver diseases are the leading cause of morbidity and mortality in the United States. Since primary biliary cirrhosis (PBC) is a chronic liver disease, it is associated with significant disease burden and unmet medical needs with regard to treatments. There is much excitement today about the ... more >>
    K. Kowdley, MD, AGAF, FAASLD, FACP, FACG, FASGE
  • Primary Biliary Cirrhosis — PBC and NASH: Progress on the Horizon – Webcast
  • Chronic liver diseases, such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), are leading causes of morbidity and mortality in the United States. PBC and NASH differ with respect to their epidemiology, presentation, management options, and response to treatment. The burden of these ... more >>
    A. Sanyal, MD
  • Multiple Myeloma — Focus on the Role of Proteasome Inhibitors in the Management of Multiple Myeloma – Webcast
  • Clinicians need to know how to incorporate proteasome inhibitors into treatment plans for patients with multiple myeloma, whether they are newly diagnosed or are experiencing relapsed/refractory disease. Join our co-faculty Sagar Lonial, MD, and Kenneth C. Anderson, MD, for this webcast, Focus on the Role of ... more >>
    S. Lonial, MD
  • Pulmonology — Making Sense of New and Emerging Treatment Options for COPD – Webcast
  • Recent advances have led to important changes in the paradigm for the treatment of COPD. Join Dr. Barry Make and Dr. James Donohue as they discuss the current emphasis on personalized treatment based on expanded factors in patient assessment, together with the development of new and emerging treatment options ... more >>
    B. Make, MD
  • Rheumatoid Arthritis — Case Study in Rheumatoid Arthritis: Treating Early Rheumatoid Arthritis to Target Remission – Case Study
  • This activity of the Mastery in RA program describes a real-life case of a young patient who is diagnosed with early, aggressive rheumatoid arthritis (RA). This case emphasizes the importance of individualizing an aggressive treat-to-target treatment plan for early RA to target early remission.
    J. Tesser, MD
  • Ankylosing Spondylitis — Initiating Treatment for AS With a TNF Inhibitor After Lack of Response to NSAIDs – Case Study
  • Guidelines for the treatment of axial spondyloarthritis and ankylosing spondylitis (AS) have recently been published. The recommended first-line treatment of patients with active AS is nonsteroidal anti-inflammatory drugs (NSAIDs), but some patients continue to have active disease despite this treatment. This ... more >>
    L. Gensler, MD
  • Rheumatoid Arthritis — Case Study in Rheumatoid Arthritis: Best Practices for the Use of Traditional DMARDs and Initiating Biologic Therapy – Case Study
  • Rheumatoid arthritis is an inflammatory arthritis that can have a significant negative impact upon a patient’s quality of life and ability to perform his normal daily activities. Many treatment options and strategies are available for the treatment of this disease. This case illustrates the real-life scenario ... more >>
    M. Weisman, MD
  • Chronic Heart Failure — Managing a Patient With Chest Pain and a Rapid Heart Rate Presenting to the Emergency Department – Case Study
  • While the underlying causes of heart failure may differ, most patients present with a similar clinical picture. This case illustrates the real-life clinical scenario of a patient who presents with chest pain, tachycardia, and volume overload and is diagnosed with congestive heart failure. Throughout the case ... more >>
    N. Uriel, MD
  • Ankylosing Spondylitis — Importance of Early Diagnosis and Referral for Ankylosing Spondylitis – Case Study
  • Guidelines have recently been published for the treatment of axial spondyloarthritis (AxSpA) and ankylosing spondylitis (AS). Prior to initiating treatment, however, patients must first be diagnosed. This case illustrates the real-life clinical scenario of a patient who presents with chronic lower back and ... more >>
    J. Reveille, MD
  • Multiple Sclerosis — Treatment of a Patient With Relapsing-Remitting Multiple Sclerosis Who Develops Secondary-Progressive Multiple Sclerosis – Case Study
  • Although there are now many disease-modifying agents available for the treatment of relapsing-remitting multiple sclerosis (RRMS), patients with progressive MS have fewer options. This case illustrates the real-life case scenario of a patient with RRMS who develops secondary-progressive MS, illustrating the ... more >>
    J. Schafer, MD, FAAN
  • Multiple Sclerosis — Relapsing-Remitting Multiple Sclerosis Patient Who Relapses on Current Treatment – Case Study
  • There are now many disease-modifying agents available for the treatment of relapsing-remitting multiple sclerosis (RRMS), each with its own unique efficacy and safety profile. This case illustrates the real-life case scenario of a patient with RRMS who has breakthrough disease activity on her first therapy, ... more >>
    J. Bowen, MD
  • Multiple Sclerosis — Managing Relapsing-Remitting Multiple Sclerosis in a Patient Who Has Failed Three Disease-Modifying Therapies – Case Study
  • Choosing the appropriate therapy for a patient with relapsing-remitting multiple sclerosis (RRMS) with breakthrough disease can be difficult; there are now many disease-modifying treatments available, each with their own efficacy and safety profiles. This case illustrates the real-life case scenario of a ... more >>
    E. Alvarez, MD, PhD, MSCI
  • Migraine — Acute Treatment of Episodic Migraine (Moderate/Severe) in a Patient Averse to Injections – Case Study
  • Treatment for acute migraine is most effective when administered early in the attack. However, in patients whose migraine attacks progress to peak severity over a short period of time, oral agents may not provide adequate relief. In this case, Dr. Stewart Tepper discusses nonoral agents and treatment ... more >>
    D. Friedman, MD, MPH
  • Chronic Heart Failure — A Hispanic Female Presents With Heart Failure and Preserved Ejection Fraction – Case Study
  • Comorbidities can have a large effect on treatment and outcomes for patients with heart failure. This case illustrates the real-life scenario of a Hispanic patient with multiple comorbidities, including diabetes, obesity, and hypertension, who develops heart failure with a preserved ejection fraction. The ... more >>
    I. Pina, MD, MPH